9-35676116-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001216.3(CA9):āc.657G>Cā(p.Glu219Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,613,754 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001216.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CA9 | NM_001216.3 | c.657G>C | p.Glu219Asp | missense_variant | 4/11 | ENST00000378357.9 | NP_001207.2 | |
CA9 | XM_047423849.1 | c.657G>C | p.Glu219Asp | missense_variant | 4/6 | XP_047279805.1 | ||
CA9 | XM_047423850.1 | c.657G>C | p.Glu219Asp | missense_variant | 4/6 | XP_047279806.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CA9 | ENST00000378357.9 | c.657G>C | p.Glu219Asp | missense_variant | 4/11 | 1 | NM_001216.3 | ENSP00000367608.4 | ||
CA9 | ENST00000493245.1 | n.-47G>C | upstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152238Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000162 AC: 4AN: 247368Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134550
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461398Hom.: 0 Cov.: 33 AF XY: 0.00000550 AC XY: 4AN XY: 727008
GnomAD4 genome AF: 0.0000459 AC: 7AN: 152356Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 24, 2024 | The c.657G>C (p.E219D) alteration is located in exon 4 (coding exon 4) of the CA9 gene. This alteration results from a G to C substitution at nucleotide position 657, causing the glutamic acid (E) at amino acid position 219 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at